Zetia (Ezetimibe) Antitrust v. Merck & Company, Incorporated
| MERCK & COMPANY, INCORPORATED, MSP SINGAPORE CO. LLC, MERCK SHARP & DOHME CORPORATION, GLENMARK PHARMACEUTICALS, LTD., SCHERING CORPORATION, GLENMARK GENERICS INC., USA and SCHERING PLOUGH CORPORATION |
| In re: ZETIA (EZETIMIBE) ANTITRUST LITIGATION |
| CESAR CASTILLO, INC., individually and on behalf of all those similarly situated, FWK HOLDINGS, LLC, ROCHESTER DRUG COOPERATIVE, INC., ON BEHALF OF ITSELF AND ALL OTHERS SIMILARLY SITUATED and ROCHESTER DRUG COOPERATIVE, INC. |
| 20-2184 |
| November 2, 2020 |
| U.S. Court of Appeals, Fourth Circuit |
| Other |
Opinions
We have the following opinions for this case:
| Description |
|---|
|
|
Docket Report
This docket was last retrieved on December 8, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
|
|
| Filing 44 APPEARANCE OF COUNSEL by Erin C. Burns for FWK Holdings, LLC. [1000858104] [20-2184] Erin Burns [Entered: 12/02/2020 11:24 AM] |
| Filing 43 RESPONSE/ANSWER by Cesar Castillo, Inc., FWK Holdings, LLC and Rochester Drug Cooperative, Inc. to Motion [ # 42 ]. Nature of response: in opposition. [20-2184] William Monroe [Entered: 12/01/2020 01:44 PM] |
| Filing 42 MOTION by Glenmark Generics INC., USA, Glenmark Pharmaceuticals, Ltd., Merck & Company, Incorporated, Merck Sharp & Dohme Corporation, MSP Singapore Co. LLC, Schering Corporation and Schering Plough Corporation to extend filing time for reply brief until February 23, 2021.. Date and method of service: 11/30/2020 ecf. [1000856267] [20-2184] Daniel Adler [Entered: 11/30/2020 08:06 PM] |
| Filing 41 OBJECTION to DOCKETING STATEMENT by Cesar Castillo, Inc., FWK Holdings, LLC and Rochester Drug Cooperative, Inc.. [20-2184] David Sorensen [Entered: 11/30/2020 06:43 PM] |
| Filing 40 Corrected Customized BRIEFING ORDER filed -- FRAP 30(c) Schedule. Paper copy requirements are temporarily suspended unless the case is under pre-argument review or being scheduled for argument, in which case a total of four paper copies of formal briefs and appendices are required. Page-Proof Opening Brief due: 01/04/2021. Page-Proof Response Brief due: 02/02/2021. Appendix under FRAP 30(c) due: 02/05/2021. All Briefs in Final Form due 7 days after FRAP 30(c) Appendix served. [20-2184] AB [Entered: 11/24/2020 02:59 PM] |
| Filing 39 (ENTRY RESTRICTED) Customized BRIEFING ORDER filed -- FRAP 30(c) Schedule. Paper copy requirements are temporarily suspended unless the case is under pre-argument review or being scheduled for argument, in which case a total of four paper copies of formal briefs and appendices are required. Page-Proof Opening Brief due: 01/04/2021. Page-Proof Response Brief due: 02/02/2021. Appendix under FRAP 30(c) due: 02/16/2021. All Briefs in Final Form due 7 days after FRAP 30(c) Appendix served. [20-2184]--[Edited 11/24/2020 by AB] AB [Entered: 11/24/2020 02:55 PM] |
|
|
|
|
| Filing 36 MOTION by Glenmark Generics INC., USA, Glenmark Pharmaceuticals, Ltd., Merck & Company, Incorporated, Merck Sharp & Dohme Corporation, MSP Singapore Co. LLC, Schering Corporation and Schering Plough Corporation to proceed with a deferred appendix. Date and method of service: 11/23/2020 ecf. [1000853348] [20-2184] Daniel Adler [Entered: 11/23/2020 02:00 PM] |
| Filing 35 APPEARANCE OF COUNSEL by Ellen T. Noteware for Rochester Drug Cooperative, Inc.. [1000851789] [20-2184] Ellen Noteware [Entered: 11/19/2020 04:18 PM] |
| Filing 34 APPEARANCE OF COUNSEL by Marc C. Greco for Cesar Castillo, Inc., FWK Holdings, LLC and Rochester Drug Cooperative, Inc.. [1000851603] [20-2184] William Monroe [Entered: 11/19/2020 01:46 PM] |
| Filing 33 DOCKETING STATEMENT by Glenmark Generics INC., USA, Glenmark Pharmaceuticals, Ltd., Merck & Company, Incorporated, Merck Sharp & Dohme Corporation, MSP Singapore Co. LLC, Schering Corporation and Schering Plough Corporation. [20-2184] Daniel Adler [Entered: 11/18/2020 08:42 PM] |
| Filing 32 DISCLOSURE STATEMENT by Merck & Company, Incorporated and Schering Plough Corporation. Was any question on Disclosure Form answered yes? Yes [1000850900] [20-2184] Daniel Adler [Entered: 11/18/2020 08:39 PM] |
| Filing 31 DISCLOSURE STATEMENT by Merck Sharp & Dohme Corporation, Schering Corporation and MSP Singapore Co. LLC. Was any question on Disclosure Form answered yes? Yes [1000850899] [20-2184] Daniel Adler [Entered: 11/18/2020 08:36 PM] |
| Filing 30 DISCLOSURE STATEMENT by Rochester Drug Cooperative, Inc.. Was any question on Disclosure Form answered yes? No [1000850702] [20-2184] William Monroe [Entered: 11/18/2020 03:02 PM] |
| Filing 29 DISCLOSURE STATEMENT by FWK Holdings, LLC. Was any question on Disclosure Form answered yes? No [1000850698] [20-2184] William Monroe [Entered: 11/18/2020 03:00 PM] |
| Filing 28 DISCLOSURE STATEMENT by Cesar Castillo, Inc.. Was any question on Disclosure Form answered yes? No [1000850696] [20-2184] William Monroe [Entered: 11/18/2020 02:57 PM] |
| Filing 27 APPEARANCE OF COUNSEL by Jessica J. Taticchi for Glenmark Generics INC., USA and Glenmark Pharmaceuticals, Ltd.. [1000850056] [20-2184] Jessica Taticchi [Entered: 11/17/2020 10:10 PM] |
| Filing 26 APPEARANCE OF COUNSEL by Zachary M. Johns for Glenmark Generics INC., USA and Glenmark Pharmaceuticals, Ltd.. [1000850055] [20-2184] Zachary Johns [Entered: 11/17/2020 10:08 PM] |
| Filing 25 APPEARANCE OF COUNSEL by R. Brendan Fee for Glenmark Generics INC., USA and Glenmark Pharmaceuticals, Ltd.. [1000850054] [20-2184] R. Fee [Entered: 11/17/2020 10:06 PM] |
| Filing 24 APPEARANCE OF COUNSEL by Steven A. Reed for Glenmark Generics INC., USA and Glenmark Pharmaceuticals, Ltd.. [1000850053] [20-2184] Steven Reed [Entered: 11/17/2020 10:05 PM] |
| Filing 23 APPEARANCE OF COUNSEL by Jennifer L. Eaton for Glenmark Generics INC., USA and Glenmark Pharmaceuticals, Ltd.. [1000850052] [20-2184] Jennifer Eaton [Entered: 11/17/2020 10:03 PM] |
| Filing 22 APPEARANCE OF COUNSEL by Dustin M. Paul for Glenmark Generics INC., USA and Glenmark Pharmaceuticals, Ltd.. [1000850050] [20-2184] Dustin Paul [Entered: 11/17/2020 10:02 PM] |
| Filing 21 DISCLOSURE STATEMENT by Glenmark Generics INC., USA and Glenmark Pharmaceuticals, Ltd.. Was any question on Disclosure Form answered yes? Yes [1000850049] [20-2184] Richard Ottinger [Entered: 11/17/2020 10:01 PM] |
| Filing 20 APPEARANCE OF COUNSEL by Richard H. Ottinger for Glenmark Generics INC., USA and Glenmark Pharmaceuticals, Ltd.. [1000850046] [20-2184] Richard Ottinger [Entered: 11/17/2020 09:59 PM] |
| Filing 19 APPEARANCE OF COUNSEL by Nicholas Urban for Rochester Drug Cooperative, Inc.. [1000849897] [20-2184] Nicholas Urban [Entered: 11/17/2020 04:02 PM] |
| Filing 18 APPEARANCE OF COUNSEL by David F. Sorensen for Rochester Drug Cooperative, Inc.. [1000849889] [20-2184] David Sorensen [Entered: 11/17/2020 03:59 PM] |
| Filing 17 APPEARANCE OF COUNSEL by Christopher D. Dusseault for Merck & Company, Incorporated, Merck Sharp & Dohme Corporation, MSP Singapore Co. LLC, Schering Corporation and Schering Plough Corporation. [1000848350] [20-2184] Christopher Dusseault [Entered: 11/16/2020 12:02 PM] |
| Filing 16 Accelerated BRIEFING ORDER filed. Paper copy requirements are temporarily suspended unless the case is under pre-argument review or being scheduled for argument, in which case a total of four paper copies of formal briefs and appendices are required. Opening Brief and Appendix due 01/06/2021. Response Brief due 02/05/2021. Any Reply Brief due 02/26/2021. [20-2184] AB [Entered: 11/16/2020 08:31 AM] |
|
|
| Filing 14 APPEARANCE OF COUNSEL by Thomas M. Sobol for FWK Holdings, LLC. [1000847865] [20-2184] Thomas Sobol [Entered: 11/13/2020 05:51 PM] |
| Filing 12 APPEARANCE OF COUNSEL by Stephen Edward Noona for Merck & Company, Incorporated, Merck Sharp & Dohme Corporation, MSP Singapore Co. LLC, Schering Corporation and Schering Plough Corporation. [1000847594] [20-2184] Stephen Noona [Entered: 11/13/2020 02:48 PM] |
| Filing 11 APPEARANCE OF COUNSEL by Bradley J. Hamburger for Merck & Company, Incorporated, Merck Sharp & Dohme Corporation, MSP Singapore Co. LLC, Schering Corporation and Schering Plough Corporation. [1000847553] [20-2184] Bradley Hamburger [Entered: 11/13/2020 02:04 PM] |
| Filing 10 APPEARANCE OF COUNSEL by Daniel R. Adler for Merck & Company, Incorporated, Merck Sharp & Dohme Corporation, MSP Singapore Co. LLC, Schering Corporation and Schering Plough Corporation. [1000847552] [20-2184] Daniel Adler [Entered: 11/13/2020 02:00 PM] |
| Filing 9 APPEARANCE OF COUNSEL by Theodore J. Boutrous, Jr. for Merck & Company, Incorporated, Merck Sharp & Dohme Corporation, MSP Singapore Co. LLC, Schering Corporation and Schering Plough Corporation. [1000847544] [20-2184] Theodore Boutrous [Entered: 11/13/2020 01:48 PM] |
| Filing 8 RESPONSE/ANSWER by Glenmark Generics INC., USA, Glenmark Pharmaceuticals, Ltd., Merck & Company, Incorporated, Merck Sharp & Dohme Corporation, MSP Singapore Co. LLC, Schering Corporation and Schering Plough Corporation to Motion [ # 6 ], Motion [ # 6 ], notice requesting response [ # 7 ]. Nature of response: in opposition. [20-2184] Theodore Boutrous [Entered: 11/13/2020 01:45 PM] |
| Filing 7 NOTICE ISSUED to Glenmark Generics INC., USA, Glenmark Pharmaceuticals, Ltd., MSP Singapore Co. LLC, Merck & Company, Incorporated, Merck Sharp & Dohme Corporation, Schering Corporation and Schering Plough Corporation requesting response to Motion to accelerate case processing [ # 6 ], Motion to expedite decision [ # 6 ]Response due 11/23/2020.[1000846507]. [20-2184] AW [Entered: 11/12/2020 11:06 AM] |
| Filing 6 MOTION by Cesar Castillo, Inc., FWK Holdings, LLC and Rochester Drug Cooperative, Inc. to accelerate case processing. , to expedite decision. Date and method of service: 11/11/2020 ecf. [1000846035] [20-2184] William Monroe [Entered: 11/11/2020 04:08 PM] |
| Filing 5 APPEARANCE OF COUNSEL by William H. Monroe, Jr. for Cesar Castillo, Inc., FWK Holdings, LLC and Rochester Drug Cooperative, Inc.. [1000846033] [20-2184] William Monroe [Entered: 11/11/2020 03:55 PM] |
| Filing 4 DOCKETING NOTICE issued Re: [ # 1 ] case Originating case number: 2:18-md-02836-RBS-DEM. [20-2184] JR [Entered: 11/04/2020 03:00 PM] |
| Filing 3 FEE NOTICE issued to Mr. Theodore J. Boutrous, Jr., Esq., Mr. Christopher D. Dusseault, Jennifer L. Eaton, R. Brendan Fee, Zachary M. Johns, Mr. Stephen Edward Noona, Richard Hooper Ottinger, Dustin Mitchell Paul, Steven A. Reed, Jessica J. Taticchi - after grant of permission to appeal Originating case number: 2:18-md-02836-RBS-DEM. [20-2184] JR [Entered: 11/04/2020 02:59 PM] |
| Filing 2 Case transferred from miscellaneous docket 20-432. Record complete? Yes. [20-2184] TF [Entered: 11/02/2020 02:16 PM] |
| Filing 1 Case docketed. Originating case number: 2:18-md-02836-RBS-DEM. Case manager: JRice. [20-2184] TF [Entered: 11/02/2020 02:10 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.